BerandaORMP • NASDAQ
add
Oramed Pharmaceuticals, Inc.
Tutup sebelumnya
$2,39
Rentang hari
$2,32 - $2,38
Rentang tahun
$2,00 - $3,67
Kapitalisasi pasar
95,14Â jt USD
Volume Rata-Rata
198,00Â rb
Rasio P/E
23,63
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 3,09Â jt | 6,77% |
Laba bersih | -19,62Â jt | -508,91% |
Margin laba bersih | — | — |
Penghasilan per saham | -0,48 | -500,00% |
EBITDA | -3,04Â jt | -6,97% |
Tarif pajak efektif | -6,12% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 142,30Â jt | -18,70% |
Total aset | 165,08Â jt | -28,50% |
Total liabilitas | 9,56Â jt | -88,44% |
Total ekuitas | 155,52 jt | — |
Saham yang beredar | 40,31 jt | — |
Harga terhadap nilai buku | 0,61 | — |
Tingkat pengembalian aset | -4,42% | — |
Tingkat pengembalian modal | -4,64% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -19,62Â jt | -508,91% |
Kas dari operasi | -7,10Â jt | -923,20% |
Kas dari investasi | -34,26Â jt | 54,39% |
Kas dari pembiayaan | -1,29Â jt | -101,73% |
Perubahan kas bersih | -42,65Â jt | -3.183,22% |
Arus kas bebas | -277,62Â rb | 40,85% |
Tentang
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
CEO
Didirikan
2006
Situs
Karyawan
15
